Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p

References

• Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72–81.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo P, He Y, et al. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9(5):1–17.
   PubMedGoogle Scholar
• Hallager S, Ladelund S, Kjær M, et al. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study. J Viral Hepatitis. 2018;25(1):47–55.
   PubMed Web of Science ®Google Scholar
• Balachandrakumar VK, Jabbar NF, White D, et al. Diagnosis and Staging of Hepatocellular Carcinoma (HCC): from mechanisms to management. Cham Spriger. 2019;67–82.
   Google Scholar
• Kim JM, Joh J-W, N-j Y, et al. Predicting hepatocellular carcinoma recurrence beyond milan criteria after liver resection for solitary hepatocellular carcinoma. J Gastrointest Surg. 2020;24(10):2219–2227.
   PubMed Web of Science ®Google Scholar
• He J, Zhao H, Deng D, et al. Screening of significant biomarkers related with prognosis of liver cancer by lncRNA-associated ceRNAs analysis. J Cell Physiol. 2020;235(3):2464–2477.
   PubMed Web of Science ®Google Scholar
• Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16(6):860–863.
   PubMed Web of Science ®Google Scholar
• Dang Y, Wei X, Xue L, et al. Long non-coding RNA in glioma: target miRNA and signaling pathways. Clinical Laboratory. 2018;64(6):887.
   PubMedGoogle Scholar
• Li J, Li L, Yuan H, et al. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells. Cell Cycle. 2019;18(16):1965–1975.
   PubMed Web of Science ®Google Scholar
• Shang W, Adzika GK, Machuki JO. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma. Cancer Med. 2019 2;8(15):6684–6699.
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen W. Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway. RSC Adv. 2019;9(37):21381–21390.
   PubMed Web of Science ®Google Scholar
• Huang X, Gao Y, Qin J, et al. LncRNA-MIAT promoted proliferation and invasion of HCC cells via sponging miR-214. Am J Physiol Gastrointest Liver Physiol. 2017;314(5):G559.
   PubMed Web of Science ®Google Scholar
• Gong X, Liao XY, Huang MY. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/beta-catenin signaling pathway. Pathol Res Pract. 2019;215(3):564–570.
   PubMed Web of Science ®Google Scholar
• Jiang F, Wang X, Liu Q, et al. Inhibition of TGF-beta/SMAD3/NF-kappaB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett. 2014;231(1):55–61.
   PubMed Web of Science ®Google Scholar
• Liao Z, Chen L, Zhang X, et al. PTPRepsilon acts as a metastatic promoter in hepatocellular carcinoma by facilitating recruitment of SMAD3 to TGF-beta receptor 1. Hepatology. 2020;72(3):997–1012.
   PubMed Web of Science ®Google Scholar
• Zhong X, Huang G, Ma Q, et al. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Medicine (Baltimore). 2019;98(27):e16269.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xu S, Dao J, et al. Differential expression of lncRNA/miRNA/mRNA and their related functional networks during the osteogenic/odontogenic differentiation of dental pulp stem cells. J Cell Physiol. 2020;235(4):3350–3361.
   PubMed Web of Science ®Google Scholar
• Huang F, Wang B, Zeng J, et al. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncol Lett. 2018;15(4):4797–4804.
   PubMed Web of Science ®Google Scholar
• Cai Y, Zhan L, Zhang CZ, et al. Effect of Gleditsia sinesis extract on miRNA21 and PTEN gene in liver cancer rat. Zhonghua Gan Zang Bing Za Zhi. 2018;26(2):142–144.
   PubMedGoogle Scholar
• Chen H, Lan Z, Li Q, et al. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway. Artificial Cells. 2019;47(1):2098–2106.
   PubMed Web of Science ®Google Scholar
• Li J, L-m Z, Zhang C, et al. The lncRNA FEZF1-AS1 promotes the progression of colorectal cancer through regulating OTX1 and targeting miR-30a-5p. Oncol Res. 2019;28(1):51.
   PubMed Web of Science ®Google Scholar
• Zhang SL, Liu Q, Zhang Q, et al. MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1. Oncol Lett. 2017;14(4):5018–5026.
   PubMed Web of Science ®Google Scholar
• You Y-K, Luo Q, W-f W, et al. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling. J Cell Mol Med. 2019;23(8):5576–5587.
   PubMed Web of Science ®Google Scholar
• Han D, Tong YN, Jia YP, et al. lncRNA EVADR promotes proliferation and migration of human colorectal cancer cell lines. Basic Clini Med. 2018;38:174.
   Google Scholar
• Ruan X, Li P, Cao H. Identification of transcriptional regulators that bind to long noncoding RNAs by RNA Pull-Down and RNA immunoprecipitation. Methods Mol Biol. 2018;1783:185–191.
   PubMedGoogle Scholar
• Liu X, Qiu Z, Wang Z, et al. NFBD1/MDC1 participates in the regulation of proliferation and apoptosis in human laryngeal squamous cell carcinoma. Clin Trans Oncology. 2017;20(2):1–8.
   Google Scholar
• Wang G, Duan P, Liu F, et al. Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis. Bioengineered. 2021;12(2):11555–11566.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7(3):842–855.
   PubMed Web of Science ®Google Scholar
• Ridgway PF, Ziprin P, Jones TL, et al. Laparoscopic staging of pancreatic tumors induces increased invasive capacity in vitro. Surg Endosc. 2003;17(2):306–310.
   PubMed Web of Science ®Google Scholar
• Tomasello L, Cluts L, Croce CM. Experimental validation of microRNA targets: analysis of microRNA targets through Western blotting. New York NY: Humana Press; 2019.
   Google Scholar
• Jun L, Tang, Tao T, et al. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in nonalcoholic fatty liver disease. Biosci Rep. 2019;39(7):BSR20181722.
   PubMedGoogle Scholar
• Chang W-K, Lee M-Y, Tai Y-H, et al. Does epidural analgesia improve the cancer outcome in hepatocellular carcinoma after resection surgery? A retrospective analysis. J Chin Med Assoc. 2019;82(4):295–299.
   PubMed Web of Science ®Google Scholar
• Petruzziello A. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12(Suppl–1, M3):26–32.
   PubMedGoogle Scholar
• Marcon PDS, Tovo CV, Kliemann DA, et al. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: a retrospective cohort study. World J Gastroenterol. 2018;24(5):613–622.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhao H, Wang X, et al. Analysis of long noncoding RNAs highlights region-specific altered expression patterns and diagnostic roles in Alzheimer’s disease. Brief Bioinform. 2018;20(2):598.
   Web of Science ®Google Scholar
• Li Y, Zhu G, Ma Y, et al. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1. J Cell Biochem. 2019;120(12):19457–19468.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu Q, Feng S, et al. Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma. Peerj. 2017;5(7):e3575.
   PubMedGoogle Scholar
• Hua L, Wang C-Y, Yao K-H, et al. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(3):3076–3082.
   PubMed Web of Science ®Google Scholar
• Hsieh AL, Walton ZE, Altman BJ, et al. MYC and metabolism on the path to cancer. Semin Cell Dev Biol. 2015;43:11–21.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Fu C, Xu Q, et al. Long non-coding RNA CASC7 inhibits the proliferation and migration of colon cancer cells via inhibiting microRNA-21. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2017;95:1644–1653.
   PubMed Web of Science ®Google Scholar
• Zuo W, Zhang W, Xu F, et al. Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1. Cancer Cell Int. 2019;19(1):1–16.
   PubMed Web of Science ®Google Scholar
• Weiming Wu YZ, Gao E, Yang L, et al. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p. J Cell Mol Med. 2020;24(1):441–450.
   PubMed Web of Science ®Google Scholar
• Yujia Pan ST, Cui R, Fan J, et al. Xiaoguang Yu long non-coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging miR-30a-5p in hepatocellular carcinoma. Cell Physiol Biochem. 2018;50(1):108–120.
   PubMedGoogle Scholar
• Zhang Y, Yan J, Pan X. miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12. Pflügers Archiv Euro J Phys. 2019;471(10):1055–1063.
   PubMedGoogle Scholar
• Cao Q, Liu F, Ji K, et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res. 2017;36(1):29.
   PubMedGoogle Scholar